Just gonna drop this here... that's BILLIONS.
Eli Lilly had a killer 2025, with $65.2 billion in revenue (up 45% from 2024) and $20.6 billion in profit. The boost mainly came from diabetes and obesity drugs, especially Mounjaro and Zepbound, which made $36.5 billion together.